Lightnews — Scholar-powered news

Reposted by Jinoos Yazdany

Paul Sufka MD @psufka.bsky.social · Aug 11

I updated website for The COVID–19 Global Rheumatology Alliance so that the full GRA curriculum vitae is on the main page: rheum-covid.org

1 2 2

Jinoos Yazdany @jyazdanymd.bsky.social · Jul 22

Listen to @sarahpollet.bsky.social & Julia Bongiorno explain how #UCSF’s IMPACC framework supports safe, equitable, and effective AI use on a new podcast. #AIinHealthcare @ucsfdocit.bsky.social

1 1

Reposted by Jinoos Yazdany

UCSF DoC-IT @ucsfdocit.bsky.social · Jul 22

@sarahpollet.bsky.social @jyazdanymd.bsky.social @julia-adler-mils.bsky.social @saramurray.bsky.social

1 1 1

Reposted by Jinoos Yazdany

Bob Wachter @bobwachter.bsky.social · Jun 27

Thrilled to see my book on healthcare Al available for preorder! sites.prh.com/preview/6f5c...
I tried to cut through the hype, with stories & insights on everything from scribes to surgery, hallucinations to misinformation, med education to regulation. Plus "Will there be doctors?"@portfoliobooks

4 4 29

Jinoos Yazdany @jyazdanymd.bsky.social · Jun 2

If the U.S. government wants to save $$$, they should read our article on #biosimilars: link.springer.com/article/10.1...

Breaking Barriers: Essential Reforms for a Competitive and Affordable Biosimilars Market - Current Rheumatology Reports

Purpose of review This update examines the current policy landscape for biosimilars, particularly those approved for treating rheumatoid arthritis. We review recent literature and recommend policies t...

link.springer.com

1

Reposted by Jinoos Yazdany

ACR Journals @acr-journals.bsky.social · May 31

NEW Episode of the ACR Journals on Air podcast! 🎙️

Epidemiology meets clinical care—Laura Plantinga, PhD, shares insights from her research on #lupus & daily activity limitations

🎧 Listen → acr.tw/4dE1lHe

Read the study → doi.org/10.1002/acr....

#Medsky

2 5

Reposted by Jinoos Yazdany

UCSF CODEX @ucsfcodex.bsky.social · May 1

Miss the conversation on bias in healthcare AI?

🎥 Catch Paige Nong, @ajh.bsky.social, and @ryan-levi.bsky.social as they unpack real-world risks—and what it takes to evaluate AI tools responsibly.

See how the experts broke it down: codex.ucsf.edu/events/codex...

@tradeoffs.org

UCSF CODEX @ucsfcodex.bsky.social · Apr 17

🌟Register for CODEX's April webinar!

What happens when AI tools in hospitals carry bias? And how can we prevent it?

Join top researchers to talk about bias in health AI: what it looks like, who's testing for it, and what hospitals can do.

🗓️ April 30 | 9-10 a.m. PT
🔗 codex.ucsf.edu/events/codex...

1 6 3

Reposted by Jinoos Yazdany

Ted Price @tedpricethepainguy.bsky.social · Mar 30

Excellent career advice from Peter Hotez journals.plos.org/plosbiology/.... Also some good stuff here for universities to consider in the face of current challenges.

Navigating your US bioscience career into the 2030s

The coming decade might see major cuts to US Government funding for biomedicine and the mainstreaming of pseudoscience. This Perspective highlights how your biosciences PhD gives you the problem-solvi...

journals.plos.org

2 6 16

Jinoos Yazdany @jyazdanymd.bsky.social · Mar 19

I’m excited to take on this new role and do my small smart to make sure AI is safe, fair, and effective. Best part is getting to work with visionary leaders like @julia-adler-mils.bsky.social @saramurray.bsky.social @sarahpollet.bsky.social and many others

UCSF DoC-IT @ucsfdocit.bsky.social · Mar 19

🚨 Big news in AI & healthcare! Jinoos Yazdany, MD, MPH, has been named Executive Director of AI Monitoring in Clinical Care at UCSF. She’ll lead efforts to ensure AI tools are evaluated and deployed safely and effectively. Read more: docit.ucsf.edu/news/jinoos-...

@jyazdanymd.bsky.social

2 1 12

Reposted by Jinoos Yazdany

UCSF DoC-IT @ucsfdocit.bsky.social · Mar 19

🚨 Big news in AI & healthcare! Jinoos Yazdany, MD, MPH, has been named Executive Director of AI Monitoring in Clinical Care at UCSF. She’ll lead efforts to ensure AI tools are evaluated and deployed safely and effectively. Read more: docit.ucsf.edu/news/jinoos-...

@jyazdanymd.bsky.social

1 2 7

Jinoos Yazdany @jyazdanymd.bsky.social · Mar 4

www.acpjournals.org/doi/10.7326/...

Damage Control in the Wake of Political Action That Threatens the Integrity of Medical Research | Annals of Internal Medicine

www.acpjournals.org

1 3

Jinoos Yazdany @jyazdanymd.bsky.social · Feb 7

I've been waiting for this one!!!

Saori Abe @oriabe114.bsky.social · Feb 7

www.nejm.org/doi/full/10....
🆕Obinutuzumab(humanized anti-CD20 monoclonal antibody) in active #lupus nephritis 🫘
👉Phase3
📖NEJM
#Rheumsky #lupusnephritis

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis | NEJM

Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, provided significantly better renal responses than placebo in a phase 2 trial involving patients with lupus nephritis receiving stan...

www.nejm.org

1

Jinoos Yazdany @jyazdanymd.bsky.social · Feb 4

You made huge contributions @rheumcat.bsky.social! We were so lucky to have you work on the GRA❤️

1

Reposted by Jinoos Yazdany

Dr Craig R McClain @drcraigmc.bsky.social · Jan 29

Somewhere in the U.S., there’s a scientist staring at their NSF/NIH grant application wondering why they bother. This post is for you. Science and society both need you. Hang in there and know there is a whole community supporting you.

42 740 3.1K

Reposted by Jinoos Yazdany

Emily Barkley-Levenson @emilybl.bsky.social · Jan 28

Fantastic, super clear explanation by Dr. Choo of NIH grants process: takes “tens of thousands of reviewers annually on more than 1000 meetings with study sections like the one I should have been sitting in Thursday.” Even if/when the freeze ends, can’t just be restarted with a snap.
🧪

Esther Choo @choo.bsky.social · Jan 24

An explainer about how health research funding happens and why this NIH funding cycle shutdown matters: www.msnbc.com/opinion/msnb...

Opinion | I’m a health researcher. NIH’s pause on research grants could have a devastating cost.

This is a potentially devastating event — not just for the scientific community, but for all Americans.

www.msnbc.com

2 17 37

Reposted by Jinoos Yazdany

Margot Kushel MD @mkushel.bsky.social · Jan 25

Health Disparities are real & lethal. Research on ⬇️ health disparities & improving health among impacted pops is critical. The NIMHD (NIH Institute that focuses on ⬇️ disparities) website remains. But if you search NIH Health Disparities, the page is gone. Chilling.

7 20

Reposted by Jinoos Yazdany

Cristina Lanata @cristinalanata.bsky.social · Dec 19

Extremely pleased to see this published! It takes a whole division of rheumatology to be on the look out for active SLE patients in the clinics/hospital with an active flare to enroll them in research and follow them over time

clinicalepigeneticsjournal.biomedcentral.com/articles/10....

Changes in DNA methylation are associated with systemic lupus erythematosus flare remission and clinical subtypes - Clinical Epigenetics

Background Systemic lupus erythematosus (SLE) has numerous symptoms across organs and an unpredictable flare-remittance pattern. This has made it challenging to understand drivers of long-term SLE out...

clinicalepigeneticsjournal.biomedcentral.com

7 7

Reposted by Jinoos Yazdany

Natalia Vasquez Canizares @nataliavasca.bsky.social · Dec 5

We have 2 fellowship positions available (1 pediatric rheumatology, 1 med-peds rheumatology) at the Children’s Hospital at Montefiore, Bronx, NY. We welcome #IMG and sponsor both J1 and H1b visas. You will never regret being part of this outstanding team! See information below if interested!

5 3

Jinoos Yazdany @jyazdanymd.bsky.social · Nov 29

chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://zsfgmedicine.ucsf.edu/sites/zsfgmedicine.ucsf.edu/files/2024-11/DOM%20Newsletter-November%202024%20%281%29.pdf

Jinoos Yazdany @jyazdanymd.bsky.social · Nov 29

Dr. Jenny Mandal's Rheumatology Access Expansion (RAE: raeinitiative.org) has trained 111 primary care clinicians on Native American reservations around the U.S. to care for people with #RA. Read about her inspiring work at the link below. #rheumsky #UCSFrheum

1 6

Jinoos Yazdany @jyazdanymd.bsky.social · Nov 23

This trial is very interesting - we need ways to prevent LN before it happens! Early MMF helps but for how long should rx continue? Also need to further define who will benefit. jamanetwork.com/journals/jam...

Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus

This randomized clinical trial investigates whether early application of mycophenolate mofetil improves long-term outcomes in patients with newly diagnosed systemic lupus erythematosus with a high tit...

jamanetwork.com

1 3

Jinoos Yazdany @jyazdanymd.bsky.social · Nov 22

Good questions - it is interesting that we see the same patterns in UK study and in this US one. There is something going on (neither study designed to address causality). I think some detailed qualitative work would be a good next step.

1 2

Jinoos Yazdany @jyazdanymd.bsky.social · Nov 21

#ACR24 Older patients, those in low nSES areas, and certain racial/ethnic groups less likely to get b/tsDMARDs, trends that did not change over last decade.#RISE-registry. www.heal.com/news/rheumat...

Age, racial gaps in b/tsDMARD use for rheumatoid arthritis show ‘surprising’ stability

WASHINGTON — Disparities in the use of biologic and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis, including among older, Black and Asian patients, have not c...

www.healio.com

1 1 7

Reposted by Jinoos Yazdany

Rheum Cat @rheumcat.bsky.social · Nov 20

For the second year, @ACRheum’s Global Engagement Committee along with @rheum_covid leaders were able to review over 60 applications and provide travel awards to these accomplished individuals to attend #ACR24

1 1 4

Reposted by Jinoos Yazdany

Rheum Cat @rheumcat.bsky.social · Nov 20

And I found this old tweet from @philipcrobinson from the first @ACRheum I attended in 2016, and it reminds me of why we do what we do, and what this program is about

@jyazdanymd.bsky.social
@profbeckyg.bsky.social
@nicoladalbeth.bsky.social

Phil Robinson tweeting at ACR staff Donna Hoyne in 2016 about the success of #ACR16

3 8